Back to Search Start Over

Telomere Length and the Risk of Alzheimer's Disease: The Rotterdam Study

Authors :
Fani, L. (Lana)
Hilal, S. (Saima)
Sedaghat, S. (Sanaz)
Broer, L. (Linda)
Licher, S. (Silvan)
Arp, P.P. (Pascal)
van Meurs, J.B.J. (Joyce B J)
Ikram, M.K. (Kamran)
Ikram, M.A. (Arfan)
Fani, L. (Lana)
Hilal, S. (Saima)
Sedaghat, S. (Sanaz)
Broer, L. (Linda)
Licher, S. (Silvan)
Arp, P.P. (Pascal)
van Meurs, J.B.J. (Joyce B J)
Ikram, M.K. (Kamran)
Ikram, M.A. (Arfan)
Publication Year :
2020

Abstract

There is a wide interest in biomarkers that capture the burden of detrimental factors as these accumulate with the passage of time, i.e., increasing age. Telomere length has received considerable attention as such a marker, because it is easily quantified and it may aid in disentangling the etiology of dementia or serve as predictive marker. We determined the association of telomere length with risk of Alzheimer's disease and all-cause dementia in a population-based setting. Within the Rotterdam Study, we performed quantitative PCR to measure mean leukocyte telomere length in blood. We determined the association of telomere length with risk of Alzheimer's disease until 2016, using Cox regression models. Of 1,961 participants (mean age 71.4±9.3 years, 57.1% women) with a median follow-up of 8.3 years, 237 individuals were diagnosed with Alzheimer's disease. We found a U-shaped associat

Details

Database :
OAIster
Notes :
application/pdf, Journal of Alzheimer's Disease vol. 73 no. 2, pp. 707-714, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1143371086
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.3233.JAD-190759